The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats

J D Taurog, J A Richardson, J T Croft, W A Simmons, M Zhou, J L Fernández-Sueiro, E Balish, R E Hammer, J D Taurog, J A Richardson, J T Croft, W A Simmons, M Zhou, J L Fernández-Sueiro, E Balish, R E Hammer

Abstract

A number of inflammatory disease states occur with greatly increased frequency in individuals inheriting the human major histocompatibility complex class I allele HLA-B27. In a minority of cases, namely those with B27-associated reactive arthritis, there is good evidence that the disease state is triggered by infection with an enteric or genitourinary bacterial pathogen. For the majority of B27-associated disease, no definite pathogenetic role for bacteria has been established. However, in these latter cases intestinal inflammation can often be demonstrated, and it sometimes occupies a major part of the clinical picture. Rats transgenic for B27 are known to develop a disorder resembling B27-associated human disease, with prominent intestinal, joint, skin, and male genital inflammatory lesions. We report here that B27 transgenic rats raised in a germfree environment do not develop inflammatory intestinal or peripheral joint disease, whereas the skin and genital inflammatory lesions are unaffected by the germfree state. These findings support the concept that gut and joint inflammation are pathogenetically closely related, and they provide direct evidence that the commensal gut flora play an important role in the pathogenesis of B27-associated gut and joint inflammation.

References

    1. Gut. 1971 Mar;12(3):230-5
    1. J Rheumatol. 1993 Aug;20(8):1353-8
    1. Clin Rheum Dis. 1985 Apr;11(1):1-24
    1. Infect Immun. 1986 Jan;51(1):240-9
    1. Mol Cell Biol. 1986 Jul;6(7):2551-61
    1. Clin Exp Rheumatol. 1989 Sep-Oct;7(5):499-504
    1. J Immunol. 1990 Oct 15;145(8):2539-44
    1. Cell. 1990 Nov 30;63(5):1099-112
    1. Mol Cell Biol. 1991 Nov;11(11):5479-86
    1. Nature. 1991 Oct 10;353(6344):566-9
    1. J Immunol. 1992 Jun 1;148(11):3554-9
    1. J Immunol. 1993 May 1;150(9):4168-78
    1. Br J Rheumatol. 1993 Aug;32(8):729-33
    1. Cell. 1993 Oct 22;75(2):253-61
    1. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9330-4
    1. N Engl J Med. 1983 Dec 29;309(26):1606-15

Source: PubMed

3
구독하다